21/04/2014 05:38:26 Free Membership Login

   

AEterna Zentaris, Inc.

Visual Financials
Company Name: AEterna Zentaris, Inc.
Ticker Symbol: AEZS
WWW Address: http://www.aezsinc.com
CEO: Jurgen Engel
No. of Employees: 81
Common Issue Type: CS
Business Description:AEterna Zentaris, Inc., is an oncology and endocrinology drug development company investigating treatments for various unmet medical needs.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 1.15 Up 0.03 1.01 1.31 1.13 1.16 1.12 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 65.0 56.5 0.00 0.24 0.00 4.5 0.0 2.18 - 0.99
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close1.15$
PE Ratio - LTM4.5
Market Capitalisation65.0mil
Latest Shares Outstanding56.5mil
Earnings pS (EPS)0.24$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee415,617$
Effective Tax Rate0.0%
Float45.3mil
Float as % of Shares Outstanding1.0%
Foreign Sales34mil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue1.80%
Research & Devlopment (R&D) as % of Revenue3.40%
Gross Profit Margin99.2%
EBITDA Margin-401.3%
Pre-Tax Profit Margin-36.6%
Assets Turnover9.7%
Return on Assets (ROA)10.7%
Return on Equity (ROE)131.4%
Return on Capital Invested (ROCI)102.3%
Current Ratio6.3
Leverage Ratio (Assets/Equity)3.5
Interest Cover-17.0
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.68$
Cash pS0.00$
Book-Value pS0.30$
Tangible Book-Value pS0.11$
Cash Flow pS-0.68$
Free Cash Flow pS-0.68$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.54
Price/Tangible Book Ratio0.00
Price/Cash Flow-1.6
Price/Free Cash Flow-1.6
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----0.9-4545,6452,430,964
4 Weeks1.291.021.26-11.1-11696,00413,920,089
13 Weeks1.521.021.28-12.5-141,141,35873,046,946
26 Weeks1.740.991.43-21.7-291,648,781206,097,669
52 Weeks2.180.991.78-36.9-57973,664245,363,579
YTD1.621.02--22.2-241,556,373115,171,613
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
1.121.151.241.311.380.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue-0.310.0-0.39
Income0.0
Dividend0.0
Capital SpendingNA
R&D-16.71NA-15.81
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %74.574.5-6.6
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.730.730.71
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio55.56
Current Ratio3.4
Quick Ratio (Acid Test)3.0
Liquidity Ratio (Cash)2.52
Receivables Turnover4.1
Average Collection Period88
Working Capital/Equity-561.6
Working Capital pS1.48
Cash-Flow pS-0.76
Free Cash-Flow pS-1.23
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.26
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio109.9
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested-876.1
LT Debt/Total Liabilities0.0
Interest Cover0.0
Interest/Capital Invested0.74
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.89
Current P/E Ratio - LTM4.50
Enterprise Value (EV)/EBITDA-3.69
Enterprise Value (EV)/Free Cash Flow-1.76
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.54
Price/Cash Flow Ratio-1.6
Price/Free Cash Flow Ratio - LTM-1.6
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-21.1
5-Y Low P/E Ratio-1.1
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS0.62
Tangible Book Value pS - LTM0.11
Book Value pS - LTM0.30
Capital Invested pS-0.12
Cash pS - LTM0.00
Cash Flow pS - LTM-0.68
Free Cash Flow pS - LTM-0.68
Earnings pS (EPS)0.24
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-92.34
Free Cash Flow Margin 5YEAR AVG-65.18
Net Profit Margin-60.6
Net Profit Margin - 5YEAR AVRG.-0.3
Equity Productivity-5.03
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity-5.03
Return on Capital Invested (ROCI)304.9
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity0.50
Return on Assets (ROA)-30.2
Return on Assets (ROA) - 5YEAR AVRG.-0.2
Gross Profit Margin99.2
Gross Profit Margin - 5YEAR AVRG.0.5
EBITDA Margin - LTM-401.3
EBIT Margin - LTM-416.6
Pre-Tax Profit Margin-60.6
Pre-Tax Profit Margin - 5YEAR AVRG.-1.4
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.-1.3
EFFICIENCY RATIOS
Cash Conversion Cycle136
Revenue per Employee415,617
Net Income per Employee-252,000
Average Collection Period85
Receivables Turnover4.1
Day's Inventory Turnover Ratio51
Inventory Turnover7.1
Inventory/Sales12.1
Accounts Payble/Sales19.90
Assets/Revenue2.00
Net Working Capital Turnover0.90
Fixed Assets Turnover2.34
Total Assets Turnover0.5
Revenue per $ Cash2.18
Revenue per $ Plant15.68
Revenue per $ Common Equity-5.03
Revenue per $ Capital Invested-5.03
Selling, General & Adm/tive (SG&A) as % of Revenue36.0
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue61.2
R&D Expense as % of Revenue - 5YEAR AVRG.61.2

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq aezs140421 05:38